AARDEX group will be at the 42th Annual Conference of the German Society of Hypertension
NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 42th Annual Conference
AARDEX Group will be at the 2nd value added medicines conference 2018
NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 2nd value added medicines
AARDEX Group will be at ESPACOMP 2018
OCT-2018 : AARDEX Group will be at ESPACOMP 2018 from November 29th to December
AARDEX group will be at the Annual Meeting of the American College of Rheumatology
OCT-2018 : AARDEX group will speak at the Annual Meeting of the American College of Rheumatology
AARDEX Group will be at ISPOR Europe.
OCT-2018 : AARDEX Group will be at ISPOR Europe in Barcelona 10-14 November 2018.
New MEMS® 8 technology, the precision of a Swiss watch
AUG-2018 : The new MEMS® 8 technology has a precision comparable
Major contributions of AARDEX Group to HIV medication adherence monitoring and management
AUG-2018 : Amsterdam, 22nd International AIDS Conference: AARDEX Group presented
OECD confirms that investing in medication adherence improves health outcomes and health system efficiency
AUG-2018 : In this groundbreaking publication, the OECD discusses the importance of medication
Important NIH Funding Opportunity
JUL-2018 : The National Institutes of Health (NIH) qualified medication adherence